These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 141974)

  • 1. The effect of thymosin on patients with disseminated malignancies. A phase I study.
    Costanzi JJ; Gagliano RG; Delaney F; Harris N; Thurman GB; Sakai H; Goldstein AL; Loukas D; Cohen GB; Thomson PD
    Cancer; 1977 Jul; 40(1):14-9. PubMed ID: 141974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trials with thymosin.
    Costanzi J; Daniels J; Thurman G; Goldstein A; Hokanson J
    Ann N Y Acad Sci; 1979; 332():148-59. PubMed ID: 394635
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro and in vivo studies with thymosin in cancer patients.
    Schafer LA; Goldstein AL; Gutterman JU; Hersh EM
    Ann N Y Acad Sci; 1976; 277(00):609-20. PubMed ID: 136916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of immune balance by thymosin: potential role in the development of suppressor T-cells.
    Goldstein AL; Cohen GH; Thurman GB; Hooper JA; Rossio JL
    Adv Exp Med Biol; 1976; 66():221-8. PubMed ID: 773116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of thymosin in vitro in cancer patients and correlation with clinical course after thymosin immunotherapy.
    Chretien PB; Lipson SD; Makuch RW; Kenady DE; Cohen MH
    Ann N Y Acad Sci; 1979; 332():135-47. PubMed ID: 316979
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe combined immunodeficiency with cartilage-hair hypoplasa: in vitro response to thymosin and attempted reconstitution.
    Steele RW; Britton HA; Anderson CT; Kniker WT
    Pediatr Res; 1976 Dec; 10(12):1003-5. PubMed ID: 995498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymosin: basic properties and clinical application in the treatment of immunodeficiency diseases and cancer.
    Marshall GD; Thurman GB; Low TL; Goldstein AL
    Recent Results Cancer Res; 1980; 75():100-5. PubMed ID: 6262885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppression and reconstitution with thymosin after radiation therapy.
    Wara WM; Wara DW; Ammann AJ; Barnard JL; Phillips TL
    Int J Radiat Oncol Biol Phys; 1979 Jul; 5(7):997-1001. PubMed ID: 511632
    [No Abstract]   [Full Text] [Related]  

  • 9. Thymosin immunotherapy in patients with small cell carcinoma of the lung: correlation of in vitro studies with clinical course.
    Lipson SD; Chretien PB; Makuch R; Kenady DE; Cohen MH
    Cancer; 1979 Mar; 43(3):863-70. PubMed ID: 218717
    [No Abstract]   [Full Text] [Related]  

  • 10. Thymosin-induced increase in E-rosette-forming capacity of lymphocytes in patients with malignant neoplasms.
    Sakal H; Costanzi JJ; Loukas DF; Gagliano RG; Ritzmann SE; Goldstein AL
    Cancer; 1975 Sep; 36(3):974-6. PubMed ID: 1182684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transfer factor and thymosin in the treatment of Wiskott-Aldrich syndrome].
    Franchi F; Segni G; Stabile A; Ammirati P; Aiuti F
    Minerva Pediatr; 1978 Apr; 30(8):609-13. PubMed ID: 661768
    [No Abstract]   [Full Text] [Related]  

  • 12. T-cell levels and response to thymosin in vitro during intensive chemotherapy in cancer patients receiving thymosin.
    Goldberg NH; Lipson SD; Kenady DE; Simon RM; Cohen MH; Chretien PB
    Surg Forum; 1977; 28():151-2. PubMed ID: 214880
    [No Abstract]   [Full Text] [Related]  

  • 13. Thymosin reconstitution of T cell deficits in vitro in cancer patients.
    Kenady DE; Chretien PB; Potvin C; Simon RM
    Cancer; 1977 Feb; 39(2):575-80. PubMed ID: 300039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy of cancer with thymosin.
    Rossio JL; Goldstein AL
    World J Surg; 1977 Sep; 1(5):605-16. PubMed ID: 602234
    [No Abstract]   [Full Text] [Related]  

  • 15. Lymphocyte responsiveness to thymosin in angioimmunoblastic lymphadenopathy with lymphomatous transformation.
    Taylor SG
    Med Pediatr Oncol; 1982; 10(2):171-4. PubMed ID: 6978456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymosin for immunodeficiency diseases and cancer.
    Goldstein AL; Rossio JL
    Compr Ther; 1978 Feb; 4(2):49-57. PubMed ID: 624213
    [No Abstract]   [Full Text] [Related]  

  • 17. [Formation of immune rosettes by the cells of certain lymphoid system formations after treatment with thymosin].
    Selezneva TN; Kamenets LIa; Grinevich IuA
    Fiziol Zh (1978); 1979; 25(6):730-4. PubMed ID: 315887
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunologic reconstitution of patients with primary immunodeficiency diseases and cancer after treatment with thymosin.
    Goldstein AL; Thurman GB; Rossio JL; Costanzi JJ
    Transplant Proc; 1977 Mar; 9(1):1141-4. PubMed ID: 325742
    [No Abstract]   [Full Text] [Related]  

  • 19. Potential role of thymosin in the treatment of autoimmune diseases.
    Goldstein AL; Zatz MM; Low TL; Jacobs R
    Ann N Y Acad Sci; 1981; 377():486-95. PubMed ID: 6462093
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of thymosin in the treatment of primary immunodeficiency diseases and cancer.
    Goldstein AL; Cohen GH; Rossio JL; Thurman GB; Brown CN; Ulrich JT
    Med Clin North Am; 1976 May; 60(3):591-606. PubMed ID: 131889
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.